Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,564,841 papers from all fields of science
Search
Sign In
Create Free Account
Malignant Gastrinoma
A gastrin-producing neuroendocrine tumor. It is characterized by inappropriate secretion of gastrin and associated with Zollinger Ellison syndrome…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Endocrine system
Epithelial Cells
Epithelium
Gastrointestinal system
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Peptide receptor radioligand therapy is an effective treatment for the long‐term stabilization of malignant gastrinomas
S. Grozinsky-Glasberg
,
D. Barak
,
+6 authors
D. Gross
Cancer
2011
Corpus ID: 205661885
Gastrinomas, a rare group of neuroendocrine tumors, are responsible for severe peptic disease and diarrhea. Although symptomatic…
Expand
2008
2008
Regression of a Large Malignant Gastrinoma on Treatment with Sandostatin LAR®: A Case Report
D. Granberg
,
H. Jacobsson
,
K. Öberg
,
J. Gustavsson
,
M. Lehtihet
Digestion
2008
Corpus ID: 207620076
Gastrinomas may occur in the pancreas, duodenum or peripancreatic lymph nodes. The gastrin overproduction leads to the Zollinger…
Expand
2007
2007
Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
S. Y. Park
,
Y. Rhee
,
+5 authors
S. Lim
Experimental and clinical endocrinology…
2007
Corpus ID: 24173126
Ectopic Cushing's syndrome due to various malignancies is not uncommon. However, a few cases of ectopic Cushing's syndrome caused…
Expand
Highly Cited
2002
Highly Cited
2002
Prospective study of the antitumor efficacy of long‐term octreotide treatment in patients with progressive metastatic gastrinoma
H. Shojamanesh
,
F. Gibril
,
+4 authors
R. Jensen
Cancer
2002
Corpus ID: 39214224
Malignant pancreatic endocrine tumors (PETs) have a poor prognosis and existing antitumor treatments are unsatisfactory. Recent…
Expand
2000
2000
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumours
M. Caplin
,
W. Mielcarek
,
+5 authors
A. Hilson
Nuclear medicine communications
2000
Corpus ID: 24483394
Disseminated neuroendocrine tumours are difficult to treat and are generally not responsive to radiotherapy or chemotherapy…
Expand
Highly Cited
1986
Highly Cited
1986
Aggressive Resection of Metastatic Disease in Selected Patients with Malignant Gastrinoma
J. Norton
,
P. Sugarbaker
,
+4 authors
R. Jensen
Annals of surgery
1986
Corpus ID: 39195947
Fifteen patients with Zollinger-EIlison syndrome followed at the National Institutes of Health with extensive metastatic disease…
Expand
Highly Cited
1985
Highly Cited
1985
Benign and malignant gastrinoma.
B. Stabile
,
E. Passaro
American journal of surgery
1985
Corpus ID: 38294689
Highly Cited
1978
Highly Cited
1978
The Zollinger‐Ellison Syndrome—23 Years Later
C. Deveney
,
K. Deveney
,
L. Way
Annals of surgery
1978
Corpus ID: 28753049
The effects of recent diagnostic and therapeutic advances were assessed in 65 patients with the Zollinger-Ellison syndrome (ZES…
Expand
Review
1976
Review
1976
Successful treatment of a malignant gastrinoma with streptozotocin.
J. Hayes
,
N. O'Connell
,
T. O'neill
,
J. Fennelly
,
D. Weir
Gut
1976
Corpus ID: 21631757
The treatment with streptozotocin of a patient with metastatic gastrinoma is described. Two courses of intravenous streptozotocin…
Expand
1974
1974
Malignant Gastrinoma Following Total Gastrectomy
E. Passaro
,
H. E. Gordon
1974
Corpus ID: 71206628
Half of all patients with the Zollinger-Ellison syndrome treated by total gastrectomy will eventually die from their tumor. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE